recently recognized component of the electrical syncytium that controls gastric contractility. These cells transmit inhibitory neural signals to gastric smooth muscle cells. 8 It is likely that defects in any of these cell types could impair gastric emptying resulting in gastroparesis.
Histopathological analyses have suggested decreases in numbers of ICCs and increases in numbers of CD45-and CD68-positive cells in gastric full-thickness biopsies from diabetic and idiopathic gastroparesis patients. 14 In contrast, it has been reported that there are no changes in the PDGFRα + cell number in either group of gastroparesis patients. 9 It has also been proposed that an increased ratio of M1 relative to M2 macrophages may contribute to delayed gastric emptying in diabetic gastroparesis. 15 We have recently challenged some of these findings using qRT-PCR analysis of RNA isolated from the stomach muscularis of control and gastroparesis patients. We found that idiopathic gastroparesis is associated with decreased mRNA encoding smooth muscle cell contractile proteins and PDGFRα + without a change in mRNA encoding ICC markers. 16 The altered expression of mRNA encoding contractile proteins was correlated with decreased expression of serum response factor (SRF), a transcription factor that is crucial for regulating the differentiation state of smooth muscle cells. 17 Knockout of SRF from adult smooth muscle cells has been show to impair intestinal motility resulting in pseudo-obstruction. 18, 19 SRF can promote the proliferation, migration, or differentiation of smooth muscle cells depending on which other transcription factors and co-regulators that it interacts with. 20 One critical coregulator that promotes SRF's myogenic activity is myocardin. 21 During the biphasic remodeling that occurs in the intestine following partial obstruction, the proliferative phase is associated with decreased expression of myocardin and SRF and decreased binding of SRF to the promoters of smooth muscle contractile protein genes. 22 In contrast, in the hypertrophic phase myocardin expression is increased and more SRF is found at the promoters of contractile protein genes. 22 We have previously shown that the transcription factors FOXF1 and FOXF2 also interact with SRF and myocardin to regulate transcriptional activity within gastrointestinal smooth muscle cells. 23, 24 Loss of FOXF1 from smooth muscle cells during embryonic development resulted in early postnatal lethality that was associated with severe abnormalities in the gastrointestinal tract, including markedly dilated esophagus and stomach. 24 In contrast, loss of FOXF2 from smooth muscle cells during embryonic development resulted in an expansion of the myenteric nerve plexus that may have been associated with increased expression of PDGFb. 23 Given the known roles of FOXF, myocardin and SRF complexes in regulating the phenotype of smooth muscle cells and our previous findings of altered expression of mRNAs encoding some smooth muscle contractile proteins in gastric muscle of patients with gastroparesis, we set out to determine the potential roles of the FOXF proteins in regulating gastric emptying and contributing to the pathology of gastroparesis.
| MATERIAL S AND ME THODS

| Clinical assessment and human full-thickness stomach biopsies
This study received IRB approval from the Indiana University
Institutional Review Board (protocol #1309147354R004). Biopsies from the control group of human subjects were obtained from either non-diabetic or diabetic individuals without gastroparesis symptoms that were undergoing bariatric weight loss surgery as described previously (normal HbA1c level <1 month prior to surgery in nondiabetic group). 16 Control and gastroparesis subjects were age-and sex-matched. The average ages of the non-diabetic control and gastroparesis patients were 42.8 ± 7.8 years and 34.6 ± 10.1 years, respectively, with 11 of 14 (79%) control subjects being female compared to 14 out of 16 (87%) patients with gastroparesis. The average ages of the diabetic control and gastroparesis patients were 52.1 ± 12.1 years and 40.9 ± 10.5 years, respectively, with 78% of the diabetic control patients and 82% of the diabetic gastroparesis patients being female. Gastroparesis was defined as patients with symptoms of gastroparesis ≥3 months with delayed gastric emptying by 4-hour gastric scintigraphy or gastric bezoar with undigested foods by upper endoscopy after an overnight fast. Gastric scintigraphy was performed following consumption of a low fat egg-white meal with imaging at 0, 2, and 4 hours as described previously.
25,26
Abnormal gastric emptying was defined as 2-hour retention ≥60% or 4-hour retention ≥10%.
Surgical full-thickness biopsies from the gastroparesis patients were obtained at the time of routine pathological analysis in patients with severe idiopathic gastroparesis or at the time of gastric stimulator placement. In each case (control and gastroparesis patients), the biopsy was taken about 10 cm from the pylorus on the anterior aspect midway between the greater and lesser curvatures of the
Key Points
• Gastroparesis is a debilitating disease with complex etiology including altered transcription regulation in gastric smooth muscle. We aimed to determine the role of forkhead transcription factors in gastric smooth muscle in the pathology of gastroparesis.
• Forkhead transcription factors FOXF1 and FOXF2 are decreased in smooth muscle tissue from gastroparesis patients and knockout of Foxf1 and Foxf2 together, but not alone, from mouse smooth muscle resulted in delayed liquid gastric emptying associated with decreased expression of smooth muscle contractile proteins.
• Our findings suggest that FOXF1 and FOXF2 are required for the normal function of the stomach and that loss of these proteins may contribute to the development of gastroparesis.
stomach. All laparoscopic biopsies were obtained using linear cutting staplers. For sleeve gastrectomy subjects, the sample was obtained after the stomach was removed from the abdomen. and a Purelink Micro RNA isolation kit was used to isolate total RNA.
Contaminating DNA was removed by on-column DNase treatment.
The integrity and purity of the isolated RNA was determined using an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
Samples used had an RNA integrity number of >7. 
| qRT-PCR
| Immunofluorescence imaging
For confocal imaging, mouse tissues (stomach body or aorta) were 
| Western blotting
For Western blotting protein, lysates were generated by homogenizing frozen stomach antrum (in which the mucosa had been re- 
| Liquid gastric emptying assays
Prior to liquid gastric emptying assays, mice were deprived of food and bedding for about 18 hours. Two hours following removal of water from the mice, they were given an oral gavage of 100 µL of Rhodamine dextran in methylcellulose (2.5 mg/mL Rhodamine B dextran 70 K dissolved in 1% methylcellulose). Fifteen minutes following the gavage, the mice were euthanized by cervical dislocation and the esophagus, duodenum and ileum quickly clamped. The stomach and small intestine were then removed from the mouse.
The stomach was placed in 4 mL of saline, and the small intestine was divided into 8 equal length portions and each portion added to a tube containing 4 mL of saline. Stomach and intestinal segments were homogenized using a polytron (Kineticore, Kinematica, Luzern, Switzerland); samples were clarified by centrifugation (13 000 g for 5 minutes). Rhodamine B was detected in 100 µL aliquots of the lysates using a fluorescence plate reader (579 nm excitation, 590 nm emission.) % gastric emptying = (sum of all fluorescence − stomach fluorescence)/all fluorescence × 100 
| Statistical analysis
| RE SULTS
| FOXF expression is decreased in human patients with gastroparesis
Expression of FOXF1 and FOXF2 mRNA was measured by qRT-PCR in the isolated stomach muscularis obtained from full-thickness biopsies of control patients with no symptoms of gastroparesis and from patients with gastroparesis. Two groups of control patients were used. The first group included 14 patients undergoing bariatric weight loss surgery, five patients from sleeve gastrectomy and nine patients from Roux-en-Y bypass surgery. None of these 14 controls subjects had diabetes (normal HbA1c <1 month prior to surgery; Figure 1A ). The clinical description of these patients was described
previously. 16 The second group included 11 patients undergoing bariatric weight loss surgery that had diabetes ( Figure 1B) . We also analyzed samples from two groups of patients with gastroparesis one group with no diabetes (16 patients with idiopathic gastroparesis described previously, 16 Figure 1A ) and one group in which the patients also had diabetes (9 patients with diabetic gastroparesis, Figure 1B ).
This analysis revealed that FOXF1 and FOXF2 mRNA levels were significantly decreased in the patients with idiopathic gastroparesis ( Figure 1A) , and FOXF1 mRNA was also significantly decreased in the patients with diabetic gastroparesis ( Figure 1B ).
| Knockout of Foxf1 and Foxf2 from adult gastric smooth muscle cells
In order to determine whether loss of FOXF1 and/or FOXF2 may be contributing to the impaired gastric motility seen in human patients with gastroparesis, we generated a mouse model in which Foxf1 and/ or Foxf2 were specifically ablated in adult smooth muscle cells. To generate these mice, the previously described Foxf1 and Foxf2 floxed mice 23, 24 were crossed with mice expressing a tamoxifen regulated cre recombinase driven by the smooth muscle myosin heavy chain (Myh11)
promoter (Myh11creER(T2), 27 Figures   2 and 3) . Surprisingly, we observed a significant decrease in Foxf1 and 
| Ablation of Foxf1 and Foxf2 from adult mouse gastric smooth muscle cells results in impaired liquid gastric emptying
To determine whether loss of FOXF1 or FOXF2 in humans could be contributing to impaired gastric emptying in gastroparesis patients,
we examined the rate of liquid gastric emptying in mice lacking FOXF1, FOXF2, or both proteins. This analysis revealed that mice lacking FOXF1 and FOXF2 had significantly impaired liquid gastric emptying compared to control mice ( Figure 5 ). Neither single knockout nor double heterozygous mice exhibited this phenotype, and all control mice examined had similar liquid gastric emptying rates ( Figure 5 ).
| Foxf1 and Foxf2 double knockout mice exhibit marked decreases in mRNAs encoding contractile proteins
qRT-PCR analysis of stomach antrum obtained from Foxf1/2 double knockout mice revealed a significant decrease in mRNAs encoding contractile proteins such as MYH11, ACTA2, calponin, and SM22α ( Figure 6 ). This was accompanied by decrease in mRNAs encoding myocardin and SRF, two transcriptional activators that are known to be required for the expression of these 
| SRF and myocardin proteins are decreased in Foxf1/2 double knockout mice
To determine whether the transcriptional changes that we observed in Figure 6 also reflect changes in protein levels we performed a Western blot analysis. As there are no commercially available antibodies that can reliably detect endogenous myocardin protein, we first generated a knockin mouse in which we knocked in myc-HA epitope tags into the 3′ end of the endogenous Myocd gene (Methods). This allowed us to use antibodies to HA to detect the endogenous myocardin protein. The Myocardin HA/HA mice were crossed into the Foxf1 ff f2 ff mice so that the knockout mice had one or both alleles of Myocd tagged with HA. Western blot analysis revealed a significant decrease in myocardin, SRF, MYH11 (SM1 and SM2 isoforms), calponin, and SM22α protein levels in the stomach antrum of Foxf1/2 double knockout mice ( Figure 7) . We also observed a decrease in the SMC selective meta-vinculin. Confocal microscopy also revealed decreased myocardin-HA expression in gastric SMCs of the Foxf1/2 double knockout mice ( Figure S3 ). Mice were treated with tamoxifen at 5 weeks of age, once a day for 5 days. Four weeks later, tissues were harvested and processed for immunofluorescence microscopy as described in "Methods." Yellow arrows indicate FOXF1-and FOXF2-positive ICCs (KIT positive). CM, circular muscle; MG, myenteric ganglia
| D ISCUSS I ON
Results from our studies show that FOXF1 and FOXF2 mRNA is decreased in the stomach of human patients with gastroparesis and that loss of FOXF1 and FOXF2 proteins in adult mice is sufficient to result in delayed liquid gastric emptying. Although it is unlikely that the observed decreased expression of FOXF1 and FOXF2 mRNA in humans is in itself sufficient to cause gastroparesis, our findings from knockout mice suggest that the decreased FOXF expression may be contributing to the pathogenesis of gastroparesis in humans.
This proposal must, however, be interpreted within the limitations of our study. Firstly, we have not been able to confirm that the decreased FOXF1 and FOXF2 mRNA expression in humans is mirrored by decreased FOXF protein expression, as we have not been able to detect these proteins by Western blotting using our antibodies.
Secondly, although the Foxf1/f2 double knockout mice had impaired liquid gastric emptying and decreased expression of smooth muscle contractile proteins, we have not directly measured the contractility of the stomach muscle in these mice. Although as we have previously shown that smooth muscle-specific knockout of Foxf1 during embryonic development results in decreased contractile protein expression and impaired intestinal contractility, it seems reasonable to suggest that stomach contractility may be impaired in the adult smooth muscle-specific Foxf1/f2 double knockout mice described in the current study. 24 Finally, although gastroparesis is more prevalent in females than males in humans, we have not been able to access the effects of Foxf1/f2 knockout in female mice as the Myh11 creER(T2) transgene used in our study is located on the Y chromosome. Moreover, both these latter two groups of mice had similar rates Figure 5 ). However, it is important to note that in mice we measured gastric emptying of a liquid meal whereas in humans a solid meal is used for gastric emptying studies. It is possible that this difference in methodology is affecting the sensitivity of our detection of delayed emptying in mice. Alternatively, our findings may suggest that either humans are more sensitive to decreased FOXF expression, or more likely that there are other changes that occur in the human subjects that act together with decreased smooth muscle FOXF1/2 levels leading to impaired gastric emptying.
Consistent with this latter possibility, it has recently been shown that FOXF1 plays a critical role in ICC, which would not be predicted to be affected in our smooth muscle-specific Foxf1/2 knockout mice. 31 Furthermore, both FOXF1 and FOXF2 proteins are readily detectable in ICC of both control and smFoxf1/2 knockout mice ( Figure 4 ).
In the smFoxf1/2 knockout mice, we did observe statistically significant decrease in Kitlg mRNA, although there was no change in Kit or Ano1(Anoctamin 1) mRNA, two established markers of ICC.
32
The decreased Kitlg expression would be consistent with previous studies that showed decreased Kitlg expression in a rodent diabetic gastroparesis model. 33 However, the lack of change in the mRNAs encoding ICC markers is not consistent with the proposal that the F I G U R E 6 Knockout of Foxf1 and Foxf2 from adult mouse smooth muscle results in decreased expression of mRNAs encoding smooth muscle contractile proteins. qRT-PCR analysis of mRNA expression in antrum smooth muscle from knockout mice. Analysis is performed as described in Figure 2 ; mRNA levels in each of the knockout mice were expressed relative to a common group of tamoxifen- 
Myh11creER(T2)
+/− (F12KO) (n = 12) are treated with tamoxifen (TAM) as described in Figure 2 . Data shown are mean ± SD *P < 0.05 determined by one-way ANOVA analysis
decreased Kitlg results in decreased KIT signaling in ICC, leading to their death. 33 The role of ICC loss or dysfunction in human gastroparesis is also not fully resolved, although several immunohistological studies have suggested that gastroparesis is associated with a loss of ICC 14, 33, 34 ; in a recent study, we did not observe any detectable changes in mRNA levels of ICC markers KIT or ANO1 in patients with idiopathic gastroparesis. 16 Whether these results reflect differences between protein and mRNA expression or other differences in the methodologies employed remains to be determined.
Previously, we showed that Foxf2 knockout from SMCs during development results in elevated PDGFb expression and increased proliferation of SMCs in the longitudinal layer of the GI tract and an expansion of the myenteric plexus. 23 Although we did not observe any changes in PDGFb expression when Foxf2 was knocked out from adult smooth muscle, we did see a small but significant increase in the pan neural marker, nestin in the Foxf2 KO mice, suggesting that there may be some neural expansion in these mice ( Figure 6) .
Surprisingly, increased nestin expression was also seen in the Foxf1
KO mice yet not in the double knockout mice ( Figure 6 ). The meaning of these findings is unclear. Although the lack of change in the double knockout mice suggests that the increased nestin expression in the single knockout mice is not simply a compensatory effect due to potentially impaired muscle activity, as this would be expected to be worse in the double knockout mice.
One surprising technical finding from our study was the tamoxifen-independent activity of the Myh11creER(T2) transgene in gastric SMCs ( Figure 2 ). This transgenic mouse line has been used extensively to achieve regulated smooth muscle-specific ablation of genes, and most of these previous studies have shown tight tamoxifen-dependent regulation of the cre recombinase activity. 27, 30, 36 Our current findings suggest that although cre activity appears to be completely tamoxifendependent in vascular smooth muscle, there is a significant tamoxifenindependent cre activity in GI smooth muscle (Figure 2 ). This highlights the importance of utilizing several different mouse control lines both to monitor potential effects of tamoxifen itself and to evaluate possible hypomorphic effects of partial gene deletion from GI smooth muscle in the absence of tamoxifen. Future studies utilizing this cre transgene should thus be interpreted with caution if they do not address these issues.
Early studies on FOXF proteins showed that they are part of a signaling pathway through which sonic hedgehog (SHH) regulates patterning of the GI tract during embryonic development. 37, 38 In this pathway, SHH released from epithelial cells stimulates the transcription of Foxf1 in adjacent mesodermal cells. In turn, FOXF1 drives transcription of BMP4 which is released from the developing mesodermal cells and then feeds back to the GI epithelial cells to regulate their proliferation. Consistent, with these observations we have previously shown that deletion of Foxf1 from SMCs during development leads to impaired BMP4 expression. In the current study, we show that FOXF1 and FOXF2 appear to play partly redundant roles in regulating BMP4 expression in that we only observed a significant decrease in BMP4 mRNA expression in the double knockout mice ( Figure 6 ). Examining the effects of the decreased BMP4 on the mucosa of adult mouse stomach will be an interesting avenue for future investigation.
In summary, we have shown that expression of mRNA encoding FOXF1 and FOXF2 is decreased in human subjects with gastroparesis and that loss of both these proteins from adult smooth muscle in mice F I G U R E 
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